Quarterly report pursuant to Section 13 or 15(d)

Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)

v3.20.2
Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Accounting Policies [Abstract]            
Accumulated deficit $ (577,819)   $ (577,819)   $ (567,332)  
Cash and cash equivalent 851 $ 264 851 $ 264 $ 28 $ 60
Cash in excess of insured limit $ 600   $ 600      
Stock options granted     0 0    
Diluted shares excluded from calcuation of EPS 127,946,216 39,416,352 127,946,216 39,416,352    
Research and development $ 12 $ 154 $ 336 $ 988